Marizomib has been used in trials studying the treatment of Cancer, Melanoma, Lymphoma, Glioblastoma, and Malignant Glioma, among others.
Massachusetts General Hospital Cancer Center, Boston, Massachusetts, United States
Dana-Farber Cancer Institute, Boston, Massachusetts, United States
Bristol Myers Squibb, Summit, New Jersey, United States
Boston Children's Hospital, Boston, Massachusetts, United States
Dana-Farber Cancer Institute, Boston, Massachusetts, United States
National Institutes of Health Clinical Center, Bethesda, Maryland, United States
University of California, San Francisco, California, United States
Saint John Regional Hospital, Saint John, New Brunswick, Canada
University Hospital of Geneva, Geneva, Switzerland
Dana Farber Cancer Institute, Boston, Massachusetts, United States
University of Chicago Medical Center, Chicago, Illinois, United States
Karmanos Cancer Center, Detroit, Michigan, United States
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.